TADCASTER MEDICAL CENTRE
CRAB GARTH, TADCASTER
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 138 | 141 | 97.9% | |
| CKD 4 | 2008 | 158 | 174 | 90.8% | |
| CKD 5 | 2009 | 70 | 82 | 85.4% | |
| CKD 5 | 2010 | 7 | 8 | 87.5% | |
| CKD 5 | 2011 | 7 | 8 | 87.5% | |
| CKD 5 | 2012 | 9 | 9 | 100.0% | |
| CKD 5 | 2013 | 9 | 10 | 90.0% | |
| CKD003 | 2014 | 8 | 9 | 88.9% | |
| CKD003 | 2015 | 9 | 9 | 100.0% | |
| NM84 | 2016 | 8 | 16 | 50.0% | |
| NM84 | 2017 | 12 | 23 | 52.2% | |
| NM84 | 2019 | 9 | 14 | 64.3% | |
| NM84 | 2020 | 7 | 12 | 58.3% | |
| NM84 | 2022 | 11 | 14 | 78.6% | |
| NM84 | 2023 | 13 | 16 | 81.2% |
